Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1081874


China Asthma Drug Market Report 2009


Description: According to the 2004 Global Burden of Asthma Report, there were about 300 million asthma patients worldwide. One out of every 250 disease-related deaths was caused by asthma. In China, the incidence rate of asthma patients has continuously increased in the recent years, especially among urban children. The latest survey shows that the incidence rate is 0.7% - 1.5% in adults and 0.11% - 2.03% in children.

Asthma has been known as a costly disease that is difficult to cure. On average asthma treatment will cost a patient over RMB 3000 per year in China. Assuming a national asthma population of 15 – 18 million and a 10% treatment rate, the cost of asthma treatment will be RMB 4.5 – 5.6 billion.

The Chinese asthma drug market reached RMB 1.7 billion in 1999. In 2007, asthma drug sales were RMB 4.855 billion (USD 714 million), an increase of 22.14% from 2006

This report has systemically analyzed the Chinese asthma drug market. All drug data are based on hospital drug prescription and drug purchasing data from the hospital data monitor system that the China Nan Fang Institute of Medical and Economic Information has developed and maintained (Nan Fang Institute is a direct subsidiary of the Chinese State Food and Drug Administration, the SFDA). Sampled hospitals are from major Chinese cities across different geographic locations, including Beijing, Shanghai, Guangzhou, Nanjing, Chengdu, Chongqing, Xian, Shenyang, Harbin and Zhengzhou, covering significant percentages of all hospitals in these regions.

Market shares from all major players including multinational and Chinese pharmaceutical companies and their major asthma products are analyzed systemically based on data from significant number of Chinese hospitals. The comprehensive hospital utilization data of major asthma drugs will present you a clear picture of the competition landscape of Chinese asthma drug market and the market potential for your company’s product(s) that already marketed in China or if you are planning to bring your drugs to the China market.

This China Asthma Drug Market Report has been a Must-have reference for all levels of decision makers in pharmaceutical companies, medical device companies, healthcare investing companies and healthcare consulting companies. These unique drug prescription and utilization data can provide valuable information for new product development, marketing and strategic planning functions for pharmaceutical companies. Compared to expensive customized drug reports in China, this multi-client report provides significant savings and great cost/benefit to pharmaceutical companies and interested parties.

Products Mentioned:

- Budesonide
- Salmeterol/ Floticasone
- Montelukast
- Doxofylline
- Compound Methoxyphenamine
- Ipratropium Bromide Aerosol
- Salbutamol
- Budesonide/ Formoterol
- Asarone
- Terbutaline
- Procaterol
- Floticasone Propionate
- Theosine
- Formoterol
- Tiotropium Bromide
- Beclometasone Dipropionate
- Tranilast
- Bambuterol
- Diprophylline
- Aminophylline


Contents: Top 20 Pharmaceutical Companies in the Chinese Asthma Drug Hospital Market

Methodology

Chapter I. Clinical Application of Asthma Drugs
Section 1. Definition of Asthma
1.1 Definition
1.2 The Relationship of Asthma Airway Pathology and Impaired Pulmonary Function
Section 2. Risk Factors of Asthma
Section 3. Diagnosis and Classification of Asthma
3.1 Diagnosis of Asthma
3.2 Classification of Asthma
Section 4. Treatment of Asthma
4.1 Management Plans Are Based on Asthma Control Levels
4.2 New Status of Certain Asthma Drugs
4.3 Dose Reduction for Maintenance Therapy
Section 5. Common Asthma Drugs
5.1 Glucocorticoids Drugs
5.2 Theophylline Drugs
5.3 ß-2 Receptor Agonists
5.4 The M-receptor Blockers
5.5 a-receptor Blocker
5.6 Anti-allergic Drugs
5.6.1 The H1 receptor blocker
5.6.2 Anaphylactic Mediator Blockers
5.6.3 Leukotriene-interfering Drugs
5.7 Antibiotics
5.8 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
5.9 Diuretics
5.10 Other Inflammatory Mediator Antagonists and Cytokine Antagonists
5.11 Marrow Acidophil Progenitor Cell Inhibitors
5.12 Allergen Specific Immunotherapy (AIT)
5.13 Gene Therapy

Chapter II. Analysis of the Chinese Asthma Drug Market
Section 1. Market Size of the Chinese Asthma Drug Hospital Market
1.1 Epidemiology of Asthma in China
1.2 Theoretical Size of the Asthma Drug Market in China
1.3 Market Sizes and Annual Growth Rates of the Actual Asthma Drug Market in China (2003-2007)
Section 2 Market Shares of the Top 20 Asthma Drugs in China (2005-2007)
Section 3 Market Shares of Top 20 Pharmaceutical Companies in the China’s Asthma Drug Market (2005-2007)
Section 4 Annual Growths of Market Shares of Top 20 Asthma Drugs in China (2005-2007)
Section 5 Market Potential of the Top 20 Asthma Drugs

Chapter III. Analysis of Brand Asthma Drugs in China
Section 1: Market Shares of the Top 10 Branded Asthma Drugs in China
Section 2: Major Manufacturers of Asthma Drugs and Their Key Products in China
- GSK
- AstraZeneca
- Merck
- Boehringer Ingelheim
- Sankyo
- Heilongjiang Fuhe Huaxing
- Otsuka Pharmaceutical Ltd

Chapter IV. R&D of Asthma Drugs.
Section 1. Conventional Medicines
1.1 Glucocorticoids
1.2 ß-2 Receptor Agonist
1.3 M-receptor Blocking Agent
1.4 Theocin Category
1.5 Anti-leukotrienes medicine
1.6 Cromolyn sodium category
1.7 Antihistamine
Section 2. Non-conventional Medicines
Section 3. Immunotherapy
3.1 Specific Immunity Treatment (SIT)
3.2 BCG Vaccine (Bacillus Calmette-Guerin)
3.3 IL-4 and IL-5 Inhibitors
3.4 Anti-IgE Therapy
3.5 Neurokinin (NK) Receptor Antagonist
3.6 Others
Section 4. Gene Therapy
Section 5. Chinese Medicine Treatment
Section 6. Other Therapies

Chapter V. Brand Names, Manufacturers, and Formulas of Asthma Drugs in China
Section 1. Brand Names, Chemical Names, Manufacturers and Formulas of Asthma Drugs in China

Chapter VI. Prices of Asthma Drugs, and Asthma Drugs on the Chinese National Healthcare Insurance List
Section 1: Formulas, Packages, Retail prices, Manufacturers (for Branded Drugs only) of Asthma Drugs in China
Section 2. Asthma Drugs on the Chinese National Healthcare Insurance List
2.1. Chemical Drugs on the National Healthcare Insurance List
2.2. Traditional Chinese Medicines (TCMs) on the National Healthcare Insurance List

Appendix

Tables
Table 1. Classification of Asthma Prior to Treatme
Table 2. Control Levels of Asthma
Table 3. Market Shares of Top 20 Asthma Drugs in China 2005~2007
Table 4. Annual Sales of Top 20 Asthma Drugs in China 2005~2007
Table 5. Market Shares of the Top 20 Manufacturers of Asthma Drugs 2005-2007
Table 6. Sales of Asthma Drugs from the Top 20 Manufacturers 2005-2007
Table 7. Sales Growth of the Top 20 Asthma Drugs 2006-2007
Table 8. Market Shares of GSK Brand Asthma drugs in the Chinese Hospital Market 2003-2007
Table 9. Sales of GSK Brand Asthma drugs in the Chinese Hospital Market 2003-2007
Table 10. Branded Asthma Drugs by AstraZeneca
Table 11. Market Shares of AstraZeneca Brand Asthma Drugs in the Chinese Hospital Market 2003-2007
Table 12. Sales of AstraZeneca Brand Asthma Drugs in the Chinese Hospital Market 2003-2007
Table 13. Market Shares of Merck Brand Asthma Drugs in the Chinese Hospital Market 2003-2007
Table 14. Sales of Merck Brand Asthma Drugs in the Chinese Hospital Market 2003-2007
Table 15. Market Shares of Boehringer Ingelheim Brand Asthma Drugs in the Chinese Hospital Market 2003-2007
Table 16. Sales of Merck Boehringer Ingelheim Brand Asthma Drugs in the Chinese Hospital Market 2003-2007
Table 17. Market Shares of Sankyo Brand Asthma Drugs in the Chinese Hospital Market 2003-2007
Table 18. Sales of Sankyo Brand Asthma Drugs in the Chinese Hospital Market 2003-2007
Table 19. Market Shares of Fuhe Huaxing Brand Asthma Drugs in the Chinese Hospital Market 2003-2007
Table 20. Sales of Fuhe Huaxing Brand Asthma Drugs in the Chinese Hospital Market 2003-2007
Table 21. Market Shares of Otsuka Brand Asthma Drugs in the Chinese Hospital Market 2003-2007
Table 22. Market Shares of Otsuka Brand Asthma Drugs in the Chinese Hospital Market 2003-2007
Table 23. Brand Names, Chemical Names, Manufacturers and Formulas of Asthma Drugs in China
Table 24. Formulas, Packages, Retail prices, Manufacturers (for Branded Drugs only) of Asthma Drugs in China
Table 25. Chemical Drugs on the Chinese National Healthcare Insurance List
Table 26. Traditional Chinese Medicines (TCMs) on the National Healthcare Insurance List

Figures:

Figure 1. Asthma Management Map
Figure 2. Market Sizes of the Chinese Asthma Drug Market (2003-2007)
Figure 3. Market Potentials of the Top Asthma Drugs, China, 2007
Figure 4. Market Shares of the Top 10 Asthma Drugs 2006
Figure 5. Market Shares of the Top 10 Asthma Drugs 2007
Figure 6. Sales of GSK Asthma Drugs 2005, 2006 and 2007
Figure 7. Sales of Branded Asthma Drugs from AstraZeneca 2005, 2006 and 2007

Top 20 Pharmaceutical Companies in the Chinese Asthma Drug Hospital Market
(at least > 0.53% of the total Chinese Asthma Drug Hospital Market)
- Boehringer Ingelheim
- Zhejiang Beisheng
- AstraZenaca
- GSK
- Guangdong Huanqiu
- Guangzhou Maite-Xinghua
- Guilin Nanyao
- Hangzhou MSD China
- Heilongjiang Fuhe Huaxing
- Henan Kaifeng Kangnuo
- Hengyang Hengsheng
- Jiangsu China Medicine and Technology University
- Otsuka Pharmaceutical Co Ltd
- Qingzhou Yaowang
- Sankyo
- Shandong Hualu
- Shandong Ruiyang
- Shanghai Ethypharm
- Sichuan Chengdu Huayu
- Zhejiang Changxing


Companies Mentioned - Boehringer Ingelheim - Zhejiang Beisheng - AstraZenaca - GSK - Guangdong Huanqiu - Guangzhou Maite-Xinghua - Guilin Nanyao - Hangzhou MSD China - Heilongjiang Fuhe Huaxing - Henan Kaifeng Kangnuo - Hengyang Hengsheng - Jiangsu China Medicine and Technology University - Otsuka Pharmaceutical Co Ltd - Qingzhou Yaowang - Sankyo - Shandong Hualu - Shandong Ruiyang - Shanghai Ethypharm - Sichuan Chengdu Huayu - Zhejiang Changxing


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1081874

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/02/2012 00:34:24
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
China Asthma Drug Market Report 2009
Web Address:
http://www.researchandmarkets.com/reports/1081874
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Hard Copy €3,821.00 + EUR€ 50.00 Shipping/Handling *
CD ROM €3,439.00 + EUR€ 50.00 Shipping/Handling *
Electronic (PDF) - Site License €3,439.00
Electronic (PDF) - Enterprisewide €5,159.00
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 13/02/2012 00:34:24

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)